According to Codexis 's latest financial reports the company's total assets are $0.13 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.13 B | -45.46% |
2022-12-31 | $0.25 B | 1.63% |
2021-12-31 | $0.24 B | 11.16% |
2020-12-31 | $0.22 B | 48.68% |
2019-12-31 | $0.14 B | 88.03% |
2018-12-31 | $79.28 M | 47.85% |
2017-12-31 | $53.62 M | 50.43% |
2016-12-31 | $35.64 M | -20.16% |
2015-12-31 | $44.64 M | -7.22% |
2014-12-31 | $48.12 M | -18.22% |
2013-12-31 | $58.84 M | -41.14% |
2012-12-31 | $99.96 M | -26.45% |
2011-12-31 | $0.13 B | -3.81% |
2010-12-31 | $0.14 B | 42.68% |
2009-12-31 | $99.03 M | 39.72% |
2008-12-31 | $70.88 M | -37.57% |
2007-12-31 | $0.11 B | 143.34% |
2006-12-31 | $46.65 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 165,760.68% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 78,015.27% | ๐บ๐ธ USA |
Dupont De Nemours DD | $38.55 B | 28,130.61% | ๐บ๐ธ USA |
Balchem BCPC | $1.59 B | 1,069.59% | ๐บ๐ธ USA |